Workflow
CIXING(300307)
icon
Search documents
慈星股份(300307) - 关于为客户融资用于购买公司产品提供买方信贷担保的进展公告
2025-06-23 09:26
证券代码:300307 证券简称:慈星股份 公告编号:2025-037 宁波慈星股份有限公司 关于为客户融资用于购买公司产品提供买方信贷担保的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 一、担保情况概述 宁波慈星股份有限公司(以下简称"公司") 于2025年4月14日召开第五届 董事会第十四次会议、于2025年5月6日召开2024年度股东大会,审议通过了《关 于为客户融资用于购买公司产品提供买方信贷担保的议案》,为促进公司横机业 务的发展,解决信誉良好且需融资支持的客户付款问题,同意公司与合作银行开 展买方信贷业务,即对部分信誉良好的客户采用信贷方式销售产品,以公司和客 户签订的购销合同为基础,在公司提供连带责任保证的条件下,合作银行向客户 提供用于向公司采购产品的融资业务。根据业务开展情况,在客户为公司提供反 担保措施的前提下,公司拟向客户提供累计金额不超过50,000万元人民币的买方 信贷担保,在上述额度内可滚动使用,担保有效期为自公司2024年度股东大会审 议通过之日起至公司2025年度股东大会召开之日止。具体内容详见刊登在巨潮资 讯网的 ...
慈星股份(300307) - 2024年年度权益分派实施公告
2025-06-11 09:28
证券代码:300307 证券简称:慈星股份 公告编号:2025-036 宁波慈星股份有限公司 2024年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 宁波慈星股份有限公司(以下简称"公司"或"本公司")2024年年度权益 分派方案已获2025年5月6日召开的2024年度股东大会审议通过。现将权益分派事 宜公告如下: 一、股东大会审议通过权益分派方案情况 本公司 2024 年年度权益分派方案为:以公司现有总股本 794,248,776 股为 基数,向全体股东每 10 股派 1.000000 元人民币现金(含税;扣税后,通过深 股通持有股份的香港市场投资者、境外机构(含 QFII、RQFII)以及持有首发前 限售股的个人和证券投资基金每 10 股派 0.900000 元;持有首发后限售股、股权 激励限售股及无限售流通股的个人股息红利税实行差别化税率征收,本公司暂不 扣缴个人所得税,待个人转让股票时,根据其持股期限计算应纳税额【注】;持 有首发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红利税, 对香港投资者持有基金份额部分按 1 ...
A股内幕交易刷新历史:“提前涨停”已成日常?
Core Viewpoint - The article highlights the rampant insider trading in the A-share market, indicating that the frequency and audacity of such activities have reached unprecedented levels, overshadowing previous regulatory efforts [3][22]. Group 1: Instances of Pre-announcement Price Surge - Guokewi announced on June 6 its intention to acquire 94.366% of Zhongxin Ningbo's equity, leading to a 20% price surge on May 20, just before the announcement [5]. - Shangluo Electronics saw a 22.82% increase over four trading days prior to its announcement on June 4 regarding the acquisition of Guangzhou Ligong Technology [6]. - Bangji Technology's stock price surged on June 4 before announcing its acquisition plans [7]. - ST Jinbi experienced a 7.13% increase in the two trading days leading up to its announcement on June 4 regarding a share transfer [8]. - Huamao Technology's stock rose by 11.16% in the three trading days before its June 4 announcement of acquiring Shenzhen Fuchuang Youyue Technology [9]. Group 2: Long-term Price Increases Before Major Announcements - Honghui Fruits and Vegetables saw a 38.14% increase from April 1 to June 6, despite only a 2.97% rise on the announcement day [23]. - Maipu Medical's stock surged over 69.61% from April 7 to May 21, with significant increases noted before its announcement [23]. - Haitai Development's stock rose by 73.84% from April 7 to June 5, despite only a 1.73% increase on the announcement day [23]. - Feiyada's stock increased by 50.76% in May, with multiple days of over 9% gains leading up to its announcement on June 4 [23]. Group 3: Techniques of Insider Trading - The article discusses the strategy of creating false market signals to mislead investors, as seen in the case of Qunxing Toys, which experienced a sudden surge in trading volume before announcing a major asset restructuring [29]. - The practice of buying shares before creating favorable news is highlighted, with examples such as Diou Home, where the actual controller's shareholding was transferred to a related party [31]. - The article notes that insider trading is often concealed effectively, making it difficult for regulatory bodies to detect [34]. Group 4: Regulatory Challenges - The article emphasizes that even significant price increases do not necessarily trigger regulatory scrutiny, as companies can claim no insider information was leaked [36][38]. - Instances of companies reporting substantial price increases before announcements without facing consequences illustrate the challenges in enforcing regulations [40][41].
年内超20家上市公司重大资产重组折戟,“价格谈不拢”是主因
Sou Hu Cai Jing· 2025-06-10 07:47
Group 1 - The core issue leading to the termination of major asset restructurings among listed companies is the inability to reach an agreement on key terms, particularly the transaction price [5][6][7] - Since 2025, over 20 listed companies have announced the failure of significant asset restructurings, including well-known firms such as Guozhong Water, China Merchants Energy, and Haier Biomedical [1][5] - Companies like Yuehongyuan A and *ST Shuangcheng have also faced similar issues, primarily due to disagreements on pricing [7][11] Group 2 - Market environment changes and prolonged negotiation periods have contributed to the abandonment of restructuring plans, as seen in cases like Xinno and Antong Holdings [9][10] - The complexity of transaction structures and the presence of asset ownership issues have also been significant factors in the failure of mergers and acquisitions [11][12] - The need for effective communication and coordination among parties involved in the transaction is crucial to avoid misunderstandings and ensure successful negotiations [17][19] Group 3 - Recent policy initiatives, such as the revised "Major Asset Restructuring Management Measures," aim to enhance the merger and acquisition market's activity and success rates [14][15] - Companies are encouraged to conduct thorough due diligence and risk assessments as foundational steps in the merger process [16] - Establishing a joint working group and regular communication mechanisms can help address disputes and facilitate smoother negotiations [18][19]
慈星股份切入到国防科技行业 积极打造第二增长曲线实现战略转型
Zheng Quan Ri Bao Wang· 2025-06-04 12:49
Group 1 - Ningbo Cixing Co., Ltd. plans to acquire 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of issuing shares and cash payment, with cash not exceeding 40% of the total transaction price [1] - The acquisition is part of the company's strategic plan to optimize its industrial layout and transition towards new productive forces, aiming to enhance its core competitiveness and profitability [1][4] - The target company operates in a high-growth sector related to defense technology, with significant market potential for its health management systems and intelligent detection equipment [1][4] Group 2 - The target company's projected revenues for 2023, 2024, and the first quarter of 2025 are approximately 283.92 million, 224.55 million, and 2.84 million yuan, respectively, with net profits of 27.72 million, 54.88 million, and a loss of 11.78 million yuan [3] - The target company has a strong technological advantage with 8 core technologies, 40 invention patents (including 7 defense patents), 28 utility model patents, and 81 software copyrights [4] - The target company is recognized as a national-level "little giant" enterprise, focusing on health management and intelligent detection in the defense technology sector [4] Group 3 - The share issuance price is set at 7.16 yuan per share, which is not less than 80% of the average trading price over the previous 120 trading days [5] - There will be a 12-month lock-up period for the shares acquired by the transaction counterparties, with additional lock-up arrangements based on performance commitments [5]
慈星股份重组顺义科技布局国防科技 标的年赚5487万元总资产超4.5亿元
Chang Jiang Shang Bao· 2025-06-04 05:34
长江商报奔腾新闻记者 徐佳 国内横机行业龙头慈星股份(300307.SZ)将借重组跨界国防科技领域。 6月3日晚间,慈星股份发布重组预案。上市公司拟向李英顺、中兵国调等10名交易对方发行股份及支付 现金购买其合计持有的沈阳顺义科技股份有限公司(以下简称"顺义科技")75%股权,并募集配套资 金。 目前,标的公司的审计、评估工作尚未完成,标的资产评估结果及交易作价尚未确定。本次交易中,上 市公司现金支付部分不超过整体交易对价的40%。 长江商报奔腾新闻记者注意到,本次重组是慈星股份跨界布局国防科技行业的重要举措。 目前,顺义科技已掌握健康管理、故障诊断领域等8项核心技术,拥有发明专利40项(含国防专利7 项)、实用新型专利28项和软件著作权81项。 综上,慈星股份认为,本次交易完成后,上市公司将进一步丰富业务类型,切入到国防科技行业,打造 第二增长曲线,加快向新质生产力转型步伐,增加新的利润增长点,从而进一步提高上市公司持续盈利 能力及核心竞争力。 从盈利能力来看,重组预案显示,2023年、2024年和2025年一季度,顺义科技营业收入分别为2.84亿 元、2.25亿元、284.11万元,净利润分别为2771. ...
慈星股份拟买顺义科技75%股份 标的Q1亏损去年营收降
Zhong Guo Jing Ji Wang· 2025-06-04 02:34
Core Viewpoint - The company, Cixing Co., Ltd. (300307.SZ), is planning to acquire 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of issuing shares and cash payment, while also raising supporting funds [1][2]. Group 1: Transaction Details - The transaction involves issuing shares and cash to purchase 75% of Shenyang Shunyi Technology, with the cash portion not exceeding 40% of the total transaction price [2][3]. - The final transaction price will be determined based on an evaluation report from a qualified asset appraisal agency [2]. - The shares issued for the acquisition will be domestic RMB ordinary shares (A-shares) with a par value of RMB 1.00, and the issuance price is set at RMB 7.16 per share, which is not less than 80% of the average trading price over the previous 120 trading days [3]. Group 2: Financial Information of Target Company - Shenyang Shunyi Technology reported revenues of RMB 283.92 million, RMB 224.55 million, and RMB 2.84 million for the years 2023, 2024, and the first quarter of 2025, respectively [5]. - The net profits for the same periods were RMB 27.72 million, RMB 54.88 million, and a loss of RMB 11.78 million [5]. - As of March 31, 2025, the total assets of Shenyang Shunyi Technology were RMB 451.38 million, with total liabilities of RMB 184.78 million and equity of RMB 266.60 million [7]. Group 3: Use of Raised Funds - The funds raised from the issuance of shares will be used for cash payments in the transaction, project construction of the target company, and related taxes and intermediary fees [4].
A股盘前市场要闻速递(2025-06-04)
Jin Shi Shu Ju· 2025-06-04 01:36
重要新闻 1. 国务院:政府部门应当科学合理确定政务数据共享属性,不得通过擅自增设条件等方式阻碍、影响政 务数据共享 李强签署国务院令,公布《政务数据共享条例》。条例提到,政府部门应当科学合理确定政务数据共享 属性,不得通过擅自增设条件等方式阻碍、影响政务数据共享。对属于有条件共享类的政务数据,政府 部门应当在政务数据目录中列明共享范围、使用用途等共享使用条件。对属于不予共享类的政务数据, 政府部门应当在政务数据目录中列明理由,并明确相应的法律、行政法规以及国务院决定依据。(新华 社) 2. 商务部等五部门组织开展2025年新能源汽车下乡活动,特斯拉Model 3、Model Y车型在列 工业和信息化部、国家发展改革委、农业农村部、商务部、国家能源局组织开展2025年新能源汽车下乡 活动。选取一批新能源汽车推广比例不高、市场潜力较大的典型县域城市,举行若干场专场活动;以此 为中心辐射周边乡镇,结合地区特点开展若干场特色活动。与县域充换电设施补短板试点、智能网联汽 车"车路云一体化"试点等工作形成协同效应,推动优质资源向乡村地区倾斜。其中,特斯拉Model 3、 Model Y车型在列。 3. 商务部:希望欧方 ...
慈星股份推进定增收购军工标的 前次跨界军工被指“一地鸡毛”|速读公告
Xin Lang Cai Jing· 2025-06-03 15:59
Group 1 - Cixing Co., Ltd. is advancing its cross-border acquisition by planning to purchase 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of private placement and cash payment, with the stock resuming trading the next day [1] - The cash payment will not exceed 40% of the total transaction price, with the remaining funds raised through a private placement at an issue price of 7.16 yuan per share [1] - Cixing Co. expresses optimism about this acquisition, aiming to enter the defense technology sector and accelerate its transformation towards new productive forces [1] Group 2 - This acquisition marks Cixing Co.'s second cross-border acquisition attempt within four months, following a failed acquisition of Wuhan Minsheng, indicating a strong urgency to transition from the traditional knitting machinery industry to the defense technology field [2] - Cixing Co. previously attempted a cross-border acquisition in 2021 by acquiring a 35% stake in Beifang Guangwei Technology Co., Ltd., a manufacturer of infrared detectors primarily serving military clients [3] - The earlier acquisition was linked to a change in control of Cixing Co., which faced challenges and ultimately led to the transfer of the stake back to the controlling shareholder, Ningbo Yuren Intelligent Technology (Group) Co., Ltd. [3][4]
慈星股份拟购买顺义科技75%股份;广康生化股东拟合计减持不超过6%公司股份|公告精选
Mei Ri Jing Ji Xin Wen· 2025-06-03 13:48
Mergers and Acquisitions - Cixing Co., Ltd. plans to acquire 75% of Shenyang Shunyi Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds from no more than 35 qualified investors [1] - United Optoelectronics intends to purchase 100% of Changyi Optoelectronics from 12 shareholders via share issuance and will also raise supporting funds [2] - Inte Group's subsidiary, Inte Pharmaceutical, successfully acquired 100% equity of Zhejiang Huadong Pharmaceutical Group Co., Ltd. for 369 million yuan and signed a transaction contract with the transferor [3] Shareholding Changes - Guokang Biochemical announced that shareholders plan to collectively reduce their holdings by no more than 6% of the company's total shares, with specific plans from two major shareholders to reduce by 3% each [4] - Ruilian New Materials reported that a major shareholder, Guofu Yongyu, plans to reduce its holdings by up to 3.33%, equivalent to 573,110 shares [5] - Hongxin Technology disclosed that two major shareholders, Baiqiang and Taizhou Qixin, plan to reduce their holdings by 2.62% and 2.12% respectively [6] Risk Matters - Sinovac Biotech highlighted the high-tech, high-risk, and high-value characteristics of its innovative drugs, emphasizing the uncertainties involved in the research and approval processes [7] - Zhongheng Design noted that the revenue from its low-altitude economy and commercial aerospace projects is minimal compared to its consolidated financial statements, despite winning several contracts in these sectors [8] Restructuring - *ST Xinyan announced that it received a notice from a creditor applying for the company's restructuring and pre-restructuring procedures [10]